Literature DB >> 35201525

Trends in Prescribing Antipsychotics for Children and Adolescents in Japan: A Descriptive Epidemiological Study Using a Large-Scale Pharmacy Dataset.

Sayuri Nakane1, Sachiko Tanaka-Mizuno1,2, Chika Nishiyama1,3, Kenji Kochi1,4, Madoka Yamamoto-Sasaki1, Masato Takeuchi1, Yusuke Ogawa5, Yuko Doi6, Masaru Arai7, Yosuke Fujii6, Toshiyuki Matsunaga7, Toshiaki A Furukawa8, Koji Kawakami9.   

Abstract

Little is known about antipsychotic prescription patterns among children and adolescents in Japan, particularly in outpatient settings. We investigated the prevalence and trends of antipsychotic prescription for outpatients aged ≤ 17 years receiving a first antipsychotic prescription from 2006 to 2012 based on a large-scale dispensation dataset. Measurements included age, sex, department of diagnosis and treatment, type of prescription (monotherapy or polytherapy), antipsychotic dosage, and concomitant psychotropic drugs. Of the 10,511 patients, 65.1% were aged 13-17 years, and 52.9% were males. Second-generation antipsychotic monotherapy prescriptions increased from 53.8% in 2006 to 78.3% in 2012. Risperidone was the most frequently prescribed antipsychotic, followed by aripiprazole and olanzapine. Approximately 25.0% of patients were prescribed an initial dose less than recommended. Second-generation antipsychotic monotherapy is currently the most frequent prescription pattern among outpatients aged ≤ 17 years receiving an initial antipsychotic prescription.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  A large-scale dataset; Adolescents; Antipsychotics; Children; Outpatients; Prescribing trends

Year:  2022        PMID: 35201525     DOI: 10.1007/s10578-022-01330-x

Source DB:  PubMed          Journal:  Child Psychiatry Hum Dev        ISSN: 0009-398X


  5 in total

1.  Antipsychotic prescription in children and adolescents: an analysis of data from a German statutory health insurance company from 2005 to 2012.

Authors:  Christian J Bachmann; Thomas Lempp; Gerd Glaeske; Falk Hoffmann
Journal:  Dtsch Arztebl Int       Date:  2014-01-17       Impact factor: 5.594

2.  Prescribing Pattern of Antidepressants in Children and Adolescents: Findings from the Research on Asia Psychotropic Prescription Pattern.

Authors:  K Y Chee; A Tripathi; A Avasthi; M Y Chong; Y T Xiang; K Sim; S Kanba; Y L He; M S Lee; H F K Chiu; S Y Yang; H Kuga; P Udomratn; A J Tanra; M M Maramis; S Grover; R Mahendran; R A Kallivayalil; W W Shen; N Shinfuku; C H Tan; N Sartorius
Journal:  East Asian Arch Psychiatry       Date:  2016-03

3.  [Trends of psychotropic medication use among children and adolescents in Japan data from the national insurance claims database between 2002 and 2010].

Authors:  Yasuyuki Okumura; Junichi Fujita; Toshihiko Matsumoto
Journal:  Seishin Shinkeigaku Zasshi       Date:  2014

4.  The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis.

Authors:  Jeanette M Jerrell; Avnish Tripathi; Ali A Rizvi; Roger S McIntyre
Journal:  Prim Care Companion CNS Disord       Date:  2012-01-12

Review 5.  Profile of aripiprazole in the treatment of bipolar disorder in children and adolescents.

Authors:  Eiji Kirino
Journal:  Adolesc Health Med Ther       Date:  2014-11-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.